Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Forest Laboratories

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Forest Laboratories 2013 CNS and cardiovascular sales performance.

Forest Laboratories

AbbVie to develop argenx-partnered GARP-targeted immunotherapy

AbbVie to develop argenx-partnered GARP-targeted immunotherapy Will build on an initial $60m deal with the biotech. Abbott Laboratories spin-out AbbVie has announced plans to start developing and commercialising a new immuno-oncology drug, building on an

Indivior push to diversify boosted by schizophrenia drug approval

Indivior push to diversify boosted by schizophrenia drug approval The two approvals come as Indivior is fighting a rearguard action to protect Suboxone from a generic developed by Dr Reddy’s Laboratories.

AZ's Lynparza closes in on first line ovarian cancer use

AZ's Lynparza closes in on first line ovarian cancer use Roy Baynes, senior vice president and head of global clinical development, chief medical officer, MSD Research Laboratories (pictured) said: “Building on the strong data we’ve seen with Lynparza to date,

Meet the Judges

She has over 30 years' industry experience, which includes senior sales and marketing positions in companies such as Amersham International, Glaxo Laboratories and Lorex Synthélabo.

Karen Fraser

She has over 30 years' industry experience, which includes senior sales and marketing positions in companies such as Amersham International, Glaxo Laboratories and Lorex Synthélabo.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics